Home > > Middle East & Africa And Global Gene Therapy Market- Size, Share, Growth Rate, and Forecast
The Middle East & Africa Gene Therapy market was valued at $158.3 Million in 2023, and is projected to reach $363.6 Million by 2030 growing at a CAGR of 12.67% from 2024 to 2030. Non-Viral Vectors segment is expected to be the highest contributor to this market, with $136.0 Million in 2023, and is anticipated to reach $260.4 by 2030, registering a CAGR of 9.73%. Viral Vectors segment is anticipated to reach $103.3 Million by 2030 with the highest CAGR of 23.86%. Vector Non-Viral Vectors Viral Vectors Indication Neurological Diseases Cancer Hepatological Diseases Duchenne Muscular Dystrophy Other Indications Delivery Method In-Vivo Gene Theraoy Ex-Vivo Gene Theraoy BY REGION North America U.s. Canada Europe Germany France U.k. Italy Spain RoE Asia Japan China RoAPAC Middle East & Africa Latin America MEA